首页 > 最新文献

Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery最新文献

英文 中文
Inflammatory bowel diseases in Brazil: journey of doctors who care for patients. What is the importance? 巴西的炎症性肠病:照顾病人的医生之旅。它的重要性是什么?
IF 1.8 Pub Date : 2025-08-18 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000023e1892
Marcela Maria Silvino Craveiro, Lígia Yukie Sassaki, Eduardo Garcia Vilela, Rogério Saad Hossne
<p><strong>Background: </strong>Inflammatory bowel diseases (IBDs), represented by Crohn's disease and ulcerative colitis, are conditions whose epidemiological rates are increasing worldwide.</p><p><strong>Background: </strong>The study of IBDs and the treatment of patients with these conditions are a daily challenge for specialist doctors.</p><p><strong>Background: </strong>Understanding the profile of the doctors who treat these patients and their difficulties during treatment is essential.</p><p><strong>Background: </strong>Many adversities are related to health policies, such as access to medications and complementary tests, which compromises the adequate treatment of these patients.</p><p><strong>Background: </strong>Inflammatory bowel diseases are chronic inflammatory conditions of a recurrent nature, whose incidence and prevalence rates have increased worldwide. It is known that early diagnosis and short start of the correct indicated treatment alter the natural history of the disease, preventing complications; hence, it is necessary to know the profile of the doctors who treat these patients in Brazil and especially to understand the difficulties in care and evaluate them in relation to other variables.</p><p><strong>Background: </strong>This study showed the profile of physicians who treat inflammatory bowel disease (IBD) patients, through their registration in the Brazilian Inflammatory Bowel Disease Study Group. In addition to analyzing the physician's profile and their difficulties, the main aspects that hinder both the diagnosis and treatment of the disease, attributed to external factors, were listed. Therefore, more effective public health policies should be planned and expanded, aiming at growth and adaptation focused on IBDs.</p><p><strong>Background: </strong>Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions of a recurrent nature, whose incidence and prevalence rates have increased worldwide.</p><p><strong>Aims: </strong>The aim of this study was to profile the doctors who treat patients with IBDs in Brazil and to understand and analyze the journey and importance of this care.</p><p><strong>Methods: </strong>This is a cross-sectional study that descriptively and inferentially analyzed the pre-existing database of the Brazilian Inflammatory Bowel Disease Study Group and through this observed the reality of care for Crohn's disease and ulcerative colitis, in the country.</p><p><strong>Results: </strong>In the descriptive analysis, we found results regarding the physicians' profile such as specialty, number of patients treated with these diseases and their difficulties in accessing medications, complementary exams, and multidisciplinary team. In the statistical analysis regarding the Human Development Index of the states, the significant results were related to workplace, difficulty in accessing medications, and referral to other specialists. Regarding the association of variables with medical demographics, the
背景:以克罗恩病和溃疡性结肠炎为代表的炎症性肠病(IBDs)是世界范围内流行病学发病率不断上升的疾病。背景:IBDs的研究和患者的治疗是专科医生每天面临的挑战。背景:了解治疗这些病人的医生的概况和他们在治疗过程中的困难是必不可少的。背景:许多不利因素与卫生政策有关,例如获得药物和补充检测的机会,这影响了这些患者的适当治疗。背景:炎症性肠病是一种复发性的慢性炎症性疾病,其发病率和患病率在世界范围内呈上升趋势。众所周知,早期诊断和短期开始正确指示的治疗可以改变疾病的自然史,预防并发症;因此,有必要了解巴西治疗这些患者的医生的概况,特别是了解护理中的困难,并根据其他变量对其进行评估。背景:本研究通过巴西炎症性肠病研究组的注册,显示了治疗炎症性肠病(IBD)患者的医生概况。除了分析医生的情况及其困难之外,还列出了由于外部因素而阻碍疾病诊断和治疗的主要方面。因此,应规划和扩大更有效的公共卫生政策,旨在以肠病为重点的增长和适应。背景:炎症性肠病(IBDs)是一种复发性的慢性炎症性疾病,其发病率和患病率在世界范围内呈上升趋势。目的:本研究的目的是分析巴西治疗ibd患者的医生,并了解和分析这种护理的历程和重要性。方法:这是一项横断面研究,描述性和推断性地分析了巴西炎症性肠病研究组的现有数据库,并通过该研究观察了该国克罗恩病和溃疡性结肠炎的护理现状。结果:在描述性分析中,我们发现了关于医生概况的结果,如专业、接受这些疾病治疗的患者数量、获得药物的困难程度、补充检查和多学科团队。在对各州人类发展指数的统计分析中,显著结果与工作场所、获得药物的困难程度和转诊到其他专家有关。关于变量与医学人口统计学的关联,结果与工作场所、获得药物的困难程度和补充检查有关。结论:该研究显示了治疗ibd患者的医生和参与该调查的医生的概况。除了分析和描述医生的形象和他们的困难,我们列出了阻碍诊断和治疗的主要方面,归因于外部因素,而不管他们的现实和能力。
{"title":"Inflammatory bowel diseases in Brazil: journey of doctors who care for patients. What is the importance?","authors":"Marcela Maria Silvino Craveiro, Lígia Yukie Sassaki, Eduardo Garcia Vilela, Rogério Saad Hossne","doi":"10.1590/0102-67202025000023e1892","DOIUrl":"https://doi.org/10.1590/0102-67202025000023e1892","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Inflammatory bowel diseases (IBDs), represented by Crohn's disease and ulcerative colitis, are conditions whose epidemiological rates are increasing worldwide.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;The study of IBDs and the treatment of patients with these conditions are a daily challenge for specialist doctors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Understanding the profile of the doctors who treat these patients and their difficulties during treatment is essential.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Many adversities are related to health policies, such as access to medications and complementary tests, which compromises the adequate treatment of these patients.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Inflammatory bowel diseases are chronic inflammatory conditions of a recurrent nature, whose incidence and prevalence rates have increased worldwide. It is known that early diagnosis and short start of the correct indicated treatment alter the natural history of the disease, preventing complications; hence, it is necessary to know the profile of the doctors who treat these patients in Brazil and especially to understand the difficulties in care and evaluate them in relation to other variables.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;This study showed the profile of physicians who treat inflammatory bowel disease (IBD) patients, through their registration in the Brazilian Inflammatory Bowel Disease Study Group. In addition to analyzing the physician's profile and their difficulties, the main aspects that hinder both the diagnosis and treatment of the disease, attributed to external factors, were listed. Therefore, more effective public health policies should be planned and expanded, aiming at growth and adaptation focused on IBDs.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Inflammatory bowel diseases (IBDs) are chronic inflammatory conditions of a recurrent nature, whose incidence and prevalence rates have increased worldwide.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aims: &lt;/strong&gt;The aim of this study was to profile the doctors who treat patients with IBDs in Brazil and to understand and analyze the journey and importance of this care.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;This is a cross-sectional study that descriptively and inferentially analyzed the pre-existing database of the Brazilian Inflammatory Bowel Disease Study Group and through this observed the reality of care for Crohn's disease and ulcerative colitis, in the country.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;In the descriptive analysis, we found results regarding the physicians' profile such as specialty, number of patients treated with these diseases and their difficulties in accessing medications, complementary exams, and multidisciplinary team. In the statistical analysis regarding the Human Development Index of the states, the significant results were related to workplace, difficulty in accessing medications, and referral to other specialists. Regarding the association of variables with medical demographics, the","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1892"},"PeriodicalIF":1.8,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360708/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144980173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preventive correction of fibrinolysis with epsilon aminocaproic acid detected by thromboelastometry during liver transplantation. 血栓弹性测量法检测epsilon氨基己酸对肝移植中纤维蛋白溶解的预防性纠正。
IF 1.8 Pub Date : 2025-08-18 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000022e1891
José Carlos Rodrigues Nascimento, Luiz Henrique Freitas, Daniel Vieira Pinto, Antônia Lima Souza, Cristhyane Costa Aquino, Denise Teixeira Santos, Rogean Rodrigues Nunes
<p><strong>Background: </strong>Orthotopic liver transplantation (OLT) is a highly complex procedure.</p><p><strong>Background: </strong>OLT can be difficult to control intraoperative bleeding in patients with coagulopathies.</p><p><strong>Background: </strong>OLT may result in a high need for transfusion of blood products.</p><p><strong>Background: </strong>Epsilon aminocaproic acid (EACA) can reduce the need for transfusion of Hood products.</p><p><strong>Background: </strong>EACA can be safe with regard to complications such as thrombosis.</p><p><strong>Background: </strong>A total of 105 patients were assessed for eligibility, and 55 were excluded. The remaining 50 patients were randomized, of which 24 patients were allocated to the intervention group and the other 26 to the saline placebo group. In the analysis of the fibrinolytic and hemostatic coagulation profile by rotational thromboelastometry, fibrinolysis was significantly less frequent in patients treated with epsilon aminocaproic acid (p<0.001) compared to those in the placebo group during the anhepatic phase. In the other analyses using thromboelastometry assays such as extrinsic pathway thromboelastometry (EXTEM) (clotting time [CT], clot formation time, alpha angle, amplitude of clot firmness 10 min after CT [A10], and maximum clot firmness [MCF]) and fibrinogen-specific thromboelastometry (FIBTEM) (A10 and MCF), there was no significant difference nor postoperative complications in both groups.</p><p><strong>Background: </strong>Some studies have shown that epsilon aminocaproic acid (EACA) inhibits the binding of plasminogen to lysine residues on the surface of fibrin and prevents conversion of plasminogen to plasmin and the degradation of glycoprotein Ib receptors, thus preserving platelet function. Although EACA did not reduce blood product transfusion, the drug effectively treated all cases and was not associated with any complications of increased risk of hepatic artery and vein thrombosis or mortality within 3 months after orthotopic liver transplantation (OLT). These results support the safety of EACA as the antifibrinolytic drug of choice in OLT. However, future studies involving larger randomized clinical trials and higher doses are needed to further investigate the results.</p><p><strong>Background: </strong>Orthotopic liver transplantation (OLT) is a highly complex procedure, which can be difficult to control intraoperatively in patients with coagulopathies.</p><p><strong>Aims: </strong>The aim of this study was to evaluate the prophylactic administration of epsilon aminocaproic acid (EACA) to reduce the need for transfusion of blood products and its relevance for thrombosis.</p><p><strong>Methods: </strong>Patients were randomized into two groups: one group received EACA (20 mg/kg/h) before surgical incision until the end of OLT and a control group received a similar volume of 0.9% saline solution. Blood was collected to analyze fibrinolysis and coagulation disorders u
背景:原位肝移植(OLT)是一个高度复杂的手术。背景:OLT难以控制凝血功能障碍患者术中出血。背景:OLT可能导致对血液制品输血的高需求。背景:Epsilon氨基己酸(EACA)可以减少胡德产品的输血需求。背景:对于血栓形成等并发症,EACA是安全的。背景:共有105例患者被评估为合格,55例被排除。其余50例患者随机分组,其中干预组24例,生理盐水安慰剂组26例。在旋转血栓弹性仪分析纤维蛋白溶解和止血凝血谱时,使用epsilon氨基己酸治疗的患者纤维蛋白溶解明显减少(p背景:一些研究表明,epsilon氨基己酸(EACA)抑制纤溶酶原与纤维蛋白表面赖氨酸残基的结合,阻止纤溶酶原向纤溶酶的转化和糖蛋白Ib受体的降解,从而保持血小板功能。虽然EACA没有减少血液制品输血,但该药物有效治疗了所有病例,并且与原位肝移植(OLT)后3个月内肝动脉和静脉血栓形成风险增加或死亡的任何并发症无关。这些结果支持EACA作为OLT抗纤溶药物的安全性。然而,未来的研究需要更大的随机临床试验和更高的剂量来进一步调查结果。背景:原位肝移植(OLT)是一项高度复杂的手术,对于凝血功能障碍患者术中难以控制。目的:本研究的目的是评估epsilon氨基己酸(EACA)预防给药以减少血液制品输血的需要及其与血栓形成的相关性。方法:将患者随机分为两组:一组患者术前给予EACA (20 mg/kg/h)至OLT结束,对照组患者给予等量0.9%生理盐水溶液。收集血液,使用旋转血栓弹性测量(ROTEM®)分析纤维蛋白溶解和凝血障碍。结果:EACA治疗24例,生理盐水治疗26例。在ROTEM®对纤维蛋白溶解和止血凝血分析中,EACA治疗组纤维蛋白溶解的发生率明显降低(p结论:尽管EACA的使用没有减少血液制品的输血,但该药物有效地治疗了纤维蛋白溶解,并且与肝移植后3个月内静脉和肝动脉血栓形成风险增加或死亡率增加的任何并发症无关。
{"title":"Preventive correction of fibrinolysis with epsilon aminocaproic acid detected by thromboelastometry during liver transplantation.","authors":"José Carlos Rodrigues Nascimento, Luiz Henrique Freitas, Daniel Vieira Pinto, Antônia Lima Souza, Cristhyane Costa Aquino, Denise Teixeira Santos, Rogean Rodrigues Nunes","doi":"10.1590/0102-67202025000022e1891","DOIUrl":"https://doi.org/10.1590/0102-67202025000022e1891","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Orthotopic liver transplantation (OLT) is a highly complex procedure.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;OLT can be difficult to control intraoperative bleeding in patients with coagulopathies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;OLT may result in a high need for transfusion of blood products.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Epsilon aminocaproic acid (EACA) can reduce the need for transfusion of Hood products.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;EACA can be safe with regard to complications such as thrombosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;A total of 105 patients were assessed for eligibility, and 55 were excluded. The remaining 50 patients were randomized, of which 24 patients were allocated to the intervention group and the other 26 to the saline placebo group. In the analysis of the fibrinolytic and hemostatic coagulation profile by rotational thromboelastometry, fibrinolysis was significantly less frequent in patients treated with epsilon aminocaproic acid (p&lt;0.001) compared to those in the placebo group during the anhepatic phase. In the other analyses using thromboelastometry assays such as extrinsic pathway thromboelastometry (EXTEM) (clotting time [CT], clot formation time, alpha angle, amplitude of clot firmness 10 min after CT [A10], and maximum clot firmness [MCF]) and fibrinogen-specific thromboelastometry (FIBTEM) (A10 and MCF), there was no significant difference nor postoperative complications in both groups.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Some studies have shown that epsilon aminocaproic acid (EACA) inhibits the binding of plasminogen to lysine residues on the surface of fibrin and prevents conversion of plasminogen to plasmin and the degradation of glycoprotein Ib receptors, thus preserving platelet function. Although EACA did not reduce blood product transfusion, the drug effectively treated all cases and was not associated with any complications of increased risk of hepatic artery and vein thrombosis or mortality within 3 months after orthotopic liver transplantation (OLT). These results support the safety of EACA as the antifibrinolytic drug of choice in OLT. However, future studies involving larger randomized clinical trials and higher doses are needed to further investigate the results.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Orthotopic liver transplantation (OLT) is a highly complex procedure, which can be difficult to control intraoperatively in patients with coagulopathies.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Aims: &lt;/strong&gt;The aim of this study was to evaluate the prophylactic administration of epsilon aminocaproic acid (EACA) to reduce the need for transfusion of blood products and its relevance for thrombosis.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;Patients were randomized into two groups: one group received EACA (20 mg/kg/h) before surgical incision until the end of OLT and a control group received a similar volume of 0.9% saline solution. Blood was collected to analyze fibrinolysis and coagulation disorders u","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1891"},"PeriodicalIF":1.8,"publicationDate":"2025-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12360709/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144980526","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pancreatoduodenectomy with vascular reconstruction versus chemotherapy alone in patients with locally advanced pancreatic cancer: a systematic review. 局部晚期胰腺癌患者行胰十二指肠切除术联合血管重建与单纯化疗:一项系统综述。
IF 1.8 Pub Date : 2025-08-04 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000021e1890
Adriano Carneiro da Costa, Vitoria Alessandra Duarte, Fernando Santa Cruz, Mohamed Ali Chaouch, Jayant Kumar, Isabella Reccia, Álvaro Antonio Bandeira Ferraz, Nagy Habib

Background: Pancreatic cancer is still a terrifying condition that has a high mortality rate due to its rapid progression and treatment complexity. However, there is still no consensus on what the gold standard of treatment for locally advanced pancreatic cancer (LAPC) is.

Aims: The aim of this study was to review the current evidence-based data on treatment strategies for LAPC, comparing pancreatoduodenectomy with vascular reconstruction (PDVR) and chemotherapy alone (CA).

Methods: This systematic review was performed according to the PRISMA 2020 guidelines. Overall survival (OS) was the primary endpoint, while progression-free survival (PFS) was the secondary endpoint. The included studies were published between 2013 and 2023.

Results: A total of 16 relevant papers were found in the literature search. The median PFS duration for CA varied from 3.22 to 11.7 months, whereas the median overall survival (mOS) varied from 5.95 to 23.0 months. The mOS ranged from 12.7 to 24.9 months and the median PFS time ranged from 8.5 to 22.5 months for patients submitted to neoadjuvant therapy followed by PDVR.

Conclusions: LAPC presents worse outcomes when patients are submitted to CA with gemcitabine only, or when patients undergo upfront PDVR.

背景:胰腺癌进展迅速,治疗复杂,死亡率高,仍然是一种可怕的疾病。然而,对于局部晚期胰腺癌(LAPC)治疗的金标准是什么,目前仍未达成共识。目的:本研究的目的是回顾目前关于LAPC治疗策略的循证数据,比较胰十二指肠切除术与血管重建(PDVR)和单独化疗(CA)。方法:根据PRISMA 2020指南进行系统评价。总生存期(OS)是主要终点,而无进展生存期(PFS)是次要终点。纳入的研究发表于2013年至2023年之间。结果:在文献检索中共检索到相关论文16篇。CA的中位PFS持续时间从3.22到11.7个月不等,而中位总生存期(mOS)从5.95到23.0个月不等。接受新辅助治疗后PDVR的患者的mOS为12.7至24.9个月,中位PFS时间为8.5至22.5个月。结论:当患者仅接受吉西他滨的CA治疗或患者接受前期PDVR治疗时,LAPC的预后较差。
{"title":"Pancreatoduodenectomy with vascular reconstruction versus chemotherapy alone in patients with locally advanced pancreatic cancer: a systematic review.","authors":"Adriano Carneiro da Costa, Vitoria Alessandra Duarte, Fernando Santa Cruz, Mohamed Ali Chaouch, Jayant Kumar, Isabella Reccia, Álvaro Antonio Bandeira Ferraz, Nagy Habib","doi":"10.1590/0102-67202025000021e1890","DOIUrl":"10.1590/0102-67202025000021e1890","url":null,"abstract":"<p><strong>Background: </strong>Pancreatic cancer is still a terrifying condition that has a high mortality rate due to its rapid progression and treatment complexity. However, there is still no consensus on what the gold standard of treatment for locally advanced pancreatic cancer (LAPC) is.</p><p><strong>Aims: </strong>The aim of this study was to review the current evidence-based data on treatment strategies for LAPC, comparing pancreatoduodenectomy with vascular reconstruction (PDVR) and chemotherapy alone (CA).</p><p><strong>Methods: </strong>This systematic review was performed according to the PRISMA 2020 guidelines. Overall survival (OS) was the primary endpoint, while progression-free survival (PFS) was the secondary endpoint. The included studies were published between 2013 and 2023.</p><p><strong>Results: </strong>A total of 16 relevant papers were found in the literature search. The median PFS duration for CA varied from 3.22 to 11.7 months, whereas the median overall survival (mOS) varied from 5.95 to 23.0 months. The mOS ranged from 12.7 to 24.9 months and the median PFS time ranged from 8.5 to 22.5 months for patients submitted to neoadjuvant therapy followed by PDVR.</p><p><strong>Conclusions: </strong>LAPC presents worse outcomes when patients are submitted to CA with gemcitabine only, or when patients undergo upfront PDVR.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1890"},"PeriodicalIF":1.8,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324770/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Siewert II esophagogastric junction cancer: total gastrectomy or esophagectomy? Siewert II型食管胃结癌:全胃切除术还是食管切除术?
IF 1.8 Pub Date : 2025-08-04 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000019e1888
Durval Renato Wohnrath, Raphael de Oliveira E Silva, Raphael Leonardo Cunha Araujo

Background: The surgical approach for esophagogastric junction cancers (EJC), Siewert II, has been controversial regarding margin control, reconstruction, and lymphadenectomy extension. Therefore, predicting the need for total/subtotal esophagectomy and proximal gastrectomy (TEPG) or total gastrectomy with distal esophagectomy (TGDE) can be challenging, with each direction usually excluding the other. Historically, complication rates for TEPG are higher, affecting further systemic treatment and long-term outcomes.

Aims: The aim of this study was to describe a surgical strategy for approaching tumors such as Siewert II EGJ, with the intraoperative decision to perform total gastrectomy with lymphadenectomy D2 or esophagectomy with lymphadenectomy based on intraoperative frozen sections.

Methods: All patients underwent laparotomy, beginning with greater curvature detachment while preserving the right gastroepiploic, right and left gastric arteries; dissection of the esophageal hiatus for node harvesting; and transection of the distal esophagus and its frozen section. TGDE was preferred if the proximal margin of the distal esophagus was negative; TEPG and gastric tube reconstruction were performed through transhiatal access if the margin was positive.

Results: Among 38 Siewert II patients, 26 (69%) underwent TGDE and 12 (31%) underwent TEPG, regardless of the trend toward higher complication rates, positive margins, and shorter overall survival in the TEPG group, no statistically significant differences were detected.

Conclusions: Although no significant differences in morbidity between the two procedures were noted, type II errors could be a possible cause. This study suggests that unnecessary esophagectomies can be avoided without jeopardizing surgical or oncologic outcomes by opting for a less morbid procedure.

背景:食管胃结癌(EJC)的手术入路,Siewert II,在边缘控制、重建和淋巴结切除扩展方面一直存在争议。因此,预测全/次全食管切除术加近端胃切除术(TEPG)或全胃切除术加远端食管切除术(TGDE)的必要性是具有挑战性的,两者通常相互排斥。从历史上看,TEPG的并发症发生率较高,影响进一步的全身治疗和长期结果。目的:本研究的目的是描述一种手术策略来接近肿瘤,如Siewert II EGJ,术中决定进行全胃切除术加D2淋巴结切除术或食管切除术加基于术中冷冻切片的淋巴结切除术。方法:所有患者均行剖腹手术,从大曲率脱离开始,同时保留右胃网膜、右胃动脉和左胃动脉;食管裂孔清扫术;切开食管远端和冷冻部分。如果食管远端近缘阴性,首选TGDE;如果边缘呈阳性,则通过跨道通道进行TEPG和胃管重建。结果:在38例Siewert II患者中,26例(69%)接受了TGDE, 12例(31%)接受了TEPG,尽管TEPG组有更高的并发症发生率、阳性边缘和更短的总生存期的趋势,但没有发现统计学差异。结论:虽然两种手术的发病率没有显著差异,但II型错误可能是原因。本研究表明,通过选择一种发病率较低的手术方法,可以避免不必要的食管切除术,而不会危及手术或肿瘤预后。
{"title":"Siewert II esophagogastric junction cancer: total gastrectomy or esophagectomy?","authors":"Durval Renato Wohnrath, Raphael de Oliveira E Silva, Raphael Leonardo Cunha Araujo","doi":"10.1590/0102-67202025000019e1888","DOIUrl":"10.1590/0102-67202025000019e1888","url":null,"abstract":"<p><strong>Background: </strong>The surgical approach for esophagogastric junction cancers (EJC), Siewert II, has been controversial regarding margin control, reconstruction, and lymphadenectomy extension. Therefore, predicting the need for total/subtotal esophagectomy and proximal gastrectomy (TEPG) or total gastrectomy with distal esophagectomy (TGDE) can be challenging, with each direction usually excluding the other. Historically, complication rates for TEPG are higher, affecting further systemic treatment and long-term outcomes.</p><p><strong>Aims: </strong>The aim of this study was to describe a surgical strategy for approaching tumors such as Siewert II EGJ, with the intraoperative decision to perform total gastrectomy with lymphadenectomy D2 or esophagectomy with lymphadenectomy based on intraoperative frozen sections.</p><p><strong>Methods: </strong>All patients underwent laparotomy, beginning with greater curvature detachment while preserving the right gastroepiploic, right and left gastric arteries; dissection of the esophageal hiatus for node harvesting; and transection of the distal esophagus and its frozen section. TGDE was preferred if the proximal margin of the distal esophagus was negative; TEPG and gastric tube reconstruction were performed through transhiatal access if the margin was positive.</p><p><strong>Results: </strong>Among 38 Siewert II patients, 26 (69%) underwent TGDE and 12 (31%) underwent TEPG, regardless of the trend toward higher complication rates, positive margins, and shorter overall survival in the TEPG group, no statistically significant differences were detected.</p><p><strong>Conclusions: </strong>Although no significant differences in morbidity between the two procedures were noted, type II errors could be a possible cause. This study suggests that unnecessary esophagectomies can be avoided without jeopardizing surgical or oncologic outcomes by opting for a less morbid procedure.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1888"},"PeriodicalIF":1.8,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324771/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Variables related to locoregional and distant recurrence in esophageal cancer. 食管癌局部和远处复发的相关变量。
IF 1.8 Pub Date : 2025-08-04 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000020e1889
Sarah Fonseca, Igor Gabriel Silva Ramos, Felipe Antonio Boff Maegawa, Pedro Luiz Serrano Uson Junior, Francisco Tustumi

Background: Esophageal cancer remains one of the most aggressive malignancies of the gastrointestinal tract, with high rates of recurrence and mortality despite curative-intent surgery and adjuvant therapies. Identifying factors associated with recurrence is crucial for improving outcomes and guiding personalized treatment.

Aims: The aim of this study was to evaluate pretreatment and treatment-related variables associated with recurrence in patients with esophageal cancer undergoing surgical resection.

Methods: This retrospective study analyzed data from patients with stage I-III esophageal carcinoma who underwent esophagectomy between 2000 and 2025, using the Fundação Oncocentro de São Paulo (FOSP) database. Clinical, histological, and treatment-related variables were evaluated. Disease-free survival and recurrence patterns were assessed using Cox proportional hazards models and Fine-Gray subdistribution hazard models.

Results: A total of 2,057 patients were included, with a mean follow-up of 36.5 months (±44.8). In the multivariate analysis, advanced tumor stage (stage II: HR 1.68, 95%CI 1.21-2.33; stage III: HR 3.23, 95%CI 2.29-4.56; both p<0.01), location (middle esophagus: HR 1.31, 95%CI 1.11-1.54; p=0.001; upper esophagus: HR 1.54, 95%CI 1.21-1.96; p<0.001), and histological subtype (rare histologies: HR 2.17, 95%CI 1.35-3.49; p=0.001) were associated with worse disease-free survival. Multimodal therapy improved disease-free survival (HR 0.40, 95%CI 0.24-0.66) in stage III tumors. Squamous cell carcinoma was independently associated with locoregional recurrence (SHR 1.52, 95%CI 1.05-2.20; p=0.027). For distant recurrence, squamous cell carcinoma showed a protective effect (SHR 0.52, 95%CI 0.31-0.88; p=0.015), while high tumor grade (grade II: SHR 3.65, 95%CI 1.98-6.72; p<0.001) was associated with an increased risk. Multimodal treatments influenced recurrence patterns but did not independently predict outcomes after adjustment.

Conclusions: Tumor stage, location, and histology were strong predictors of disease-free survival after surgery for esophageal cancer. Histological subtypes significantly influenced recurrence patterns. Squamous cell carcinoma was associated with a higher risk of locoregional recurrence but a lower risk of distant metastasis compared to adenocarcinoma. Multimodal therapy demonstrated a protective effect in stage III disease.

背景:食管癌仍然是胃肠道最具侵袭性的恶性肿瘤之一,尽管有治愈意图的手术和辅助治疗,但其复发率和死亡率很高。确定与复发相关的因素对于改善预后和指导个性化治疗至关重要。目的:本研究的目的是评估与食管癌手术切除患者复发相关的预处理和治疗相关变量。方法:本回顾性研究分析了2000年至2025年间接受食管切除术的I-III期食管癌患者的数据,使用funda o Oncocentro de ssao Paulo (FOSP)数据库。评估临床、组织学和治疗相关变量。使用Cox比例风险模型和Fine-Gray亚分布风险模型评估无病生存和复发模式。结果:共纳入2057例患者,平均随访36.5个月(±44.8)。在多因素分析中,晚期肿瘤(II期:HR 1.68, 95%CI 1.21-2.33;III期:HR 3.23, 95%CI 2.29-4.56;结论:肿瘤分期、部位和组织学是食管癌术后无病生存的重要预测因素。组织学亚型显著影响复发模式。与腺癌相比,鳞状细胞癌局部复发的风险较高,但远处转移的风险较低。多模式治疗在III期疾病中显示出保护作用。
{"title":"Variables related to locoregional and distant recurrence in esophageal cancer.","authors":"Sarah Fonseca, Igor Gabriel Silva Ramos, Felipe Antonio Boff Maegawa, Pedro Luiz Serrano Uson Junior, Francisco Tustumi","doi":"10.1590/0102-67202025000020e1889","DOIUrl":"10.1590/0102-67202025000020e1889","url":null,"abstract":"<p><strong>Background: </strong>Esophageal cancer remains one of the most aggressive malignancies of the gastrointestinal tract, with high rates of recurrence and mortality despite curative-intent surgery and adjuvant therapies. Identifying factors associated with recurrence is crucial for improving outcomes and guiding personalized treatment.</p><p><strong>Aims: </strong>The aim of this study was to evaluate pretreatment and treatment-related variables associated with recurrence in patients with esophageal cancer undergoing surgical resection.</p><p><strong>Methods: </strong>This retrospective study analyzed data from patients with stage I-III esophageal carcinoma who underwent esophagectomy between 2000 and 2025, using the Fundação Oncocentro de São Paulo (FOSP) database. Clinical, histological, and treatment-related variables were evaluated. Disease-free survival and recurrence patterns were assessed using Cox proportional hazards models and Fine-Gray subdistribution hazard models.</p><p><strong>Results: </strong>A total of 2,057 patients were included, with a mean follow-up of 36.5 months (±44.8). In the multivariate analysis, advanced tumor stage (stage II: HR 1.68, 95%CI 1.21-2.33; stage III: HR 3.23, 95%CI 2.29-4.56; both p<0.01), location (middle esophagus: HR 1.31, 95%CI 1.11-1.54; p=0.001; upper esophagus: HR 1.54, 95%CI 1.21-1.96; p<0.001), and histological subtype (rare histologies: HR 2.17, 95%CI 1.35-3.49; p=0.001) were associated with worse disease-free survival. Multimodal therapy improved disease-free survival (HR 0.40, 95%CI 0.24-0.66) in stage III tumors. Squamous cell carcinoma was independently associated with locoregional recurrence (SHR 1.52, 95%CI 1.05-2.20; p=0.027). For distant recurrence, squamous cell carcinoma showed a protective effect (SHR 0.52, 95%CI 0.31-0.88; p=0.015), while high tumor grade (grade II: SHR 3.65, 95%CI 1.98-6.72; p<0.001) was associated with an increased risk. Multimodal treatments influenced recurrence patterns but did not independently predict outcomes after adjustment.</p><p><strong>Conclusions: </strong>Tumor stage, location, and histology were strong predictors of disease-free survival after surgery for esophageal cancer. Histological subtypes significantly influenced recurrence patterns. Squamous cell carcinoma was associated with a higher risk of locoregional recurrence but a lower risk of distant metastasis compared to adenocarcinoma. Multimodal therapy demonstrated a protective effect in stage III disease.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1889"},"PeriodicalIF":1.8,"publicationDate":"2025-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12324769/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144790879","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ERRATUM. 勘误表。
Pub Date : 2025-06-27 DOI: 10.1590/0102-67202025000010e1879ERRATUM

[This corrects the article doi: 10.1590/0102-67202025000010e1879].

[这更正了文章doi: 10.1590/0102-67202025000010e1879]。
{"title":"ERRATUM.","authors":"","doi":"10.1590/0102-67202025000010e1879ERRATUM","DOIUrl":"10.1590/0102-67202025000010e1879ERRATUM","url":null,"abstract":"<p><p>[This corrects the article doi: 10.1590/0102-67202025000010e1879].</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1879ERRATUM"},"PeriodicalIF":0.0,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12210392/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Retrospective longitudinal and comparative observational study between gastric bypass surgery and sleeve gastrectomy: 5-year post-operative follow-up. 胃分流术与袖式胃切除术的回顾性纵向对比观察研究:术后5年随访。
IF 1.8 Pub Date : 2025-06-27 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000016e1885
Admar Concon Filho, Sergio Henrique Bastos Damous, Jose Pinhata Otoch, Matheus Borges Coronado, Idiberto José Zotarelli Filho, Manoel Passos Galvão Neto, Vítor Ottoboni Brunaldi, Everson Luiz Almeida Artifon

Background: Among the 2.0 billion overweight individuals in the world, Brazil ranks fifth in the number of obese people, therefore requiring treatment options for obesity.

Aim: The aim of this study was to compare the percentage of total body weight loss (%TWL), change in body mass index (BMI), percentage of excess weight loss (%EWL), incidence of reflux esophagitis, and occurrence of Barrett's esophagus in obese patients undergoing gastric bypass (Roux-en-Y gastric bypass [RYGB]) and sleeve gastrectomy (SG), both techniques by videolaparoscopy.

Methods: The study included 100 consecutive patients who underwent RYGB and SG techniques, totaling 200 patients, and were followed up for 60 months, from June 2013 to July 2018.

Results: The frequency of gastroesophageal reflux disease (GERD) was lower in RYGB patients (p<0.05). At 60 months, the %EWL was 77.4±13.3 kg (RYGB) versus 80.5±17.5 kg (SG) (p<0.05). The BMI data were statistically significantly different between groups after 5 years (28.5±3.9 kg/m2 in RYGB and 31.9±5.3 kg/m2 in SG groups, p<0.05). During the follow-up, the RYGB showed higher %EWL compared to the SG (at 60 months, 80.1% vs. 59.1%, respectively, p<0.05). The %TWL was 30% for the RYGB and 19.7% for the SG (p<0.05). The RYGB had a lower frequency of reflux esophagitis and Barrett's esophagus.

Conclusions: The RYGB technique showed greater absolute weight loss, %TWL, BMI reduction, and %EWL in higher obesity classes compared to the SG technique. Additionally, RYGB had a lower frequency of reflux esophagitis and Barrett's esophagus.

背景:在全球20亿超重人群中,巴西的肥胖人数排名第五,因此需要针对肥胖的治疗方案。目的:本研究的目的是比较腹腔镜下进行胃旁路术(Roux-en-Y胃旁路术[RYGB])和袖式胃切除术(SG)的肥胖患者的总体重减轻百分比(%TWL)、体重指数(BMI)变化、超重体重减轻百分比(%EWL)、反流性食管炎的发生率和Barrett食管的发生率。方法:研究纳入100例连续接受RYGB和SG技术的患者,共计200例,随访60个月,时间为2013年6月至2018年7月。结果:RYGB患者胃食管反流病(GERD)的发生率较低(结论:与SG技术相比,RYGB技术在高肥胖类别中显示出更大的绝对体重减轻、%TWL、BMI降低和%EWL。此外,RYGB组反流性食管炎和Barrett食管的发生率较低。
{"title":"Retrospective longitudinal and comparative observational study between gastric bypass surgery and sleeve gastrectomy: 5-year post-operative follow-up.","authors":"Admar Concon Filho, Sergio Henrique Bastos Damous, Jose Pinhata Otoch, Matheus Borges Coronado, Idiberto José Zotarelli Filho, Manoel Passos Galvão Neto, Vítor Ottoboni Brunaldi, Everson Luiz Almeida Artifon","doi":"10.1590/0102-67202025000016e1885","DOIUrl":"10.1590/0102-67202025000016e1885","url":null,"abstract":"<p><strong>Background: </strong>Among the 2.0 billion overweight individuals in the world, Brazil ranks fifth in the number of obese people, therefore requiring treatment options for obesity.</p><p><strong>Aim: </strong>The aim of this study was to compare the percentage of total body weight loss (%TWL), change in body mass index (BMI), percentage of excess weight loss (%EWL), incidence of reflux esophagitis, and occurrence of Barrett's esophagus in obese patients undergoing gastric bypass (Roux-en-Y gastric bypass [RYGB]) and sleeve gastrectomy (SG), both techniques by videolaparoscopy.</p><p><strong>Methods: </strong>The study included 100 consecutive patients who underwent RYGB and SG techniques, totaling 200 patients, and were followed up for 60 months, from June 2013 to July 2018.</p><p><strong>Results: </strong>The frequency of gastroesophageal reflux disease (GERD) was lower in RYGB patients (p<0.05). At 60 months, the %EWL was 77.4±13.3 kg (RYGB) versus 80.5±17.5 kg (SG) (p<0.05). The BMI data were statistically significantly different between groups after 5 years (28.5±3.9 kg/m2 in RYGB and 31.9±5.3 kg/m2 in SG groups, p<0.05). During the follow-up, the RYGB showed higher %EWL compared to the SG (at 60 months, 80.1% vs. 59.1%, respectively, p<0.05). The %TWL was 30% for the RYGB and 19.7% for the SG (p<0.05). The RYGB had a lower frequency of reflux esophagitis and Barrett's esophagus.</p><p><strong>Conclusions: </strong>The RYGB technique showed greater absolute weight loss, %TWL, BMI reduction, and %EWL in higher obesity classes compared to the SG technique. Additionally, RYGB had a lower frequency of reflux esophagitis and Barrett's esophagus.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1885"},"PeriodicalIF":1.8,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12210394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of surgical glue and sutures in the aponeurosis synthesis of the abdominal wall in Wistar rats. 手术胶和缝合线在Wistar大鼠腹壁腱膜合成中的应用。
Pub Date : 2025-06-27 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000012e1881
Carlos Alberto Lima Utrabo, Cesar Roberto Busato, Adriana Yuriko Koga, Janete Machozeki, Mirian Guimarães, Danilo Beltrame, Elcio Machinski, Leandro Cavalcante Lipinski

Background: Adequate closure of the abdominal wall determines the success of the surgery.

Aims: The aim of this study was to study the healing of the abdominal wall of rats by comparing the use of surgical glue (2-octyl cyanoacrylate) with polypropylene 3.0 thread and poliglecaprone 3.0 thread.

Methods: A total of 60 Wistar rats were divided into two groups: Group 30 and Group 90. Each group was subdivided into three subgroups, surgical glue subgroup (C1), polypropylene subgroup (C2), and poliglecaprone subgroup (C3). An incision was made in the aponeurosis of the abdominal wall while maintaining the integrity of the parietal peritoneum. The 3 subgroups of 10 animals were euthanized on the 30th and 90th postoperative days. The abdominal wall fragments were submitted to macroscopic, histological, and tensiometric analysis.

Results: Macroscopic analysis did not show any abnormality. Tensiometry on the 30th postoperative day showed a mean rupture tension of 30.98N in subgroup C1, 27.90N in subgroup C2, and 23.90N in subgroup C3. On the 90th postoperative day, the mean rupture tension was 30.05N in subgroup C1, 44.42N in subgroup C2, and 34.78N in subgroup C3.

Conclusions: The synthesis of the abdominal aponeurosis performed with surgical glue (2-octyl cyanoacrylate) showed adequate resistance to rupture tension to maintain its integrity when compared with the synthesis with polypropylene thread or poliglecaprone thread, with both methods being equally effective.

背景:腹壁的充分闭合决定了手术的成功。目的:通过比较聚丙烯3.0线和聚甲氨酮3.0线使用手术胶(氰基丙烯酸酯2-辛酯)对大鼠腹壁愈合的影响。方法:将60只Wistar大鼠随机分为30组和90组。每组又分为手术胶亚组(C1)、聚丙烯亚组(C2)、聚甲哌酮亚组(C3)三个亚组。在腹壁的腱膜上做一个切口,同时保持腹膜壁的完整性。分别于术后第30天和第90天对3个亚组10只动物实施安乐死。腹壁碎片提交了宏观,组织学和张力分析。结果:肉眼分析未见异常。术后第30天的张力测量显示,C1亚组的平均破裂张力为30.98N, C2亚组为27.90N, C3亚组为23.90N。术后第90天,C1亚组平均断裂张力为30.05N, C2亚组为44.42N, C3亚组为34.78N。结论:与聚丙烯线或聚甲哌酮线合成腹膜膜相比,用手术胶(氰基丙烯酸酯2-辛酯)合成腹膜膜具有足够的抗破裂张力以保持其完整性,两种方法的效果相同。
{"title":"The use of surgical glue and sutures in the aponeurosis synthesis of the abdominal wall in Wistar rats.","authors":"Carlos Alberto Lima Utrabo, Cesar Roberto Busato, Adriana Yuriko Koga, Janete Machozeki, Mirian Guimarães, Danilo Beltrame, Elcio Machinski, Leandro Cavalcante Lipinski","doi":"10.1590/0102-67202025000012e1881","DOIUrl":"10.1590/0102-67202025000012e1881","url":null,"abstract":"<p><strong>Background: </strong>Adequate closure of the abdominal wall determines the success of the surgery.</p><p><strong>Aims: </strong>The aim of this study was to study the healing of the abdominal wall of rats by comparing the use of surgical glue (2-octyl cyanoacrylate) with polypropylene 3.0 thread and poliglecaprone 3.0 thread.</p><p><strong>Methods: </strong>A total of 60 Wistar rats were divided into two groups: Group 30 and Group 90. Each group was subdivided into three subgroups, surgical glue subgroup (C1), polypropylene subgroup (C2), and poliglecaprone subgroup (C3). An incision was made in the aponeurosis of the abdominal wall while maintaining the integrity of the parietal peritoneum. The 3 subgroups of 10 animals were euthanized on the 30th and 90th postoperative days. The abdominal wall fragments were submitted to macroscopic, histological, and tensiometric analysis.</p><p><strong>Results: </strong>Macroscopic analysis did not show any abnormality. Tensiometry on the 30th postoperative day showed a mean rupture tension of 30.98N in subgroup C1, 27.90N in subgroup C2, and 23.90N in subgroup C3. On the 90th postoperative day, the mean rupture tension was 30.05N in subgroup C1, 44.42N in subgroup C2, and 34.78N in subgroup C3.</p><p><strong>Conclusions: </strong>The synthesis of the abdominal aponeurosis performed with surgical glue (2-octyl cyanoacrylate) showed adequate resistance to rupture tension to maintain its integrity when compared with the synthesis with polypropylene thread or poliglecaprone thread, with both methods being equally effective.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1881"},"PeriodicalIF":0.0,"publicationDate":"2025-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12210393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144562134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ASSOCIATION BETWEEN AFFECTIVE TEMPERAMENT AND MORBID OBESITY IN BARIATRIC SURGERY CANDIDATES: A CASE-CONTROL STUDY. 在减肥手术候选人中情感气质与病态肥胖之间的关系:一项病例对照研究。
Pub Date : 2025-05-23 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000015e1884
Alexandre Karam Joaquim Mousfi, Sivan Mauer, Paulo Afonso Nunes Nassif, Marcos Fabiano Sigwalt, Ronaldo Mafia Cuenca, Orlando Jorge Martins Torres

Background: Affective temperaments are part of the spectrum of mood disorders and comprise the concepts of hyperthymia, dysthymia and cyclothymia. Numerous studies have demonstrated a strong relationship between obesity and mood disorders.

Aims: The objective of the present study was to evaluate the frequency of affective temperaments in morbidly obese individuals and controls and to establish a possible association between affective temperaments and morbid obesity.

Methods: The study evaluated 106 cases (morbidly obese) and one hundred controls (non-obese). To assess affective temperaments, the Temperament Evaluation in Memphis Pisa and San Diego - Rio de Janeiro TEMPS-Rio de Janeiro scale was applied. Depressive symptoms were assessed using the Hamilton Depression Rating Scale, anxiety symptoms using the Hamilton Anxiety Rating Scale and manic symptoms using the Young Mania Rating Scale. For univariate and multivariate analysis, logistic regression models were adjusted.

Results: The presence of at least one affective temperament was 74.5% in the morbidly obese group and 63% in the non-obese group. When comparing the two groups, the statistical analysis of the age subgroup of individuals aged 50 years or over showed an odds ratio of 2.56 (1.07-6.09) for hyperthymic temperament.

Conclusions: In the age group of 50 years or more, cases of morbid obesity are significantly more likely (2.56 times) to occur in individuals with a hyperthymic temperament. Among the three types of affective temperaments evaluated, only hyperthymia could be a risk factor for morbid obesity.

背景:情感性气质是心境障碍谱系的一部分,包括高心境、恶劣心境和循环心境的概念。大量研究表明,肥胖和情绪障碍之间存在密切关系。目的:本研究的目的是评估病态肥胖个体和对照组情感气质的频率,并建立情感气质与病态肥胖之间可能的联系。方法:对106例病态肥胖患者和100例非肥胖患者进行评价。情感气质评估采用孟菲斯比萨气质评估量表和圣地亚哥- bbb10里约热内卢气质-里约热内卢量表。抑郁症状采用汉密尔顿抑郁评定量表,焦虑症状采用汉密尔顿焦虑评定量表,躁狂症状采用青年躁狂评定量表。对于单因素和多因素分析,调整逻辑回归模型。结果:病态肥胖组存在至少一种情感气质的比例为74.5%,非肥胖组为63%。两组比较,50岁及以上个体年龄亚组的统计分析显示,胸腺亢气质的比值比为2.56(1.07-6.09)。结论:在50岁或50岁以上的年龄组中,患有胸腺亢的个体发生病态肥胖的可能性明显更高(2.56倍)。在被评估的三种情感气质中,只有高亢可能是病态肥胖的危险因素。
{"title":"ASSOCIATION BETWEEN AFFECTIVE TEMPERAMENT AND MORBID OBESITY IN BARIATRIC SURGERY CANDIDATES: A CASE-CONTROL STUDY.","authors":"Alexandre Karam Joaquim Mousfi, Sivan Mauer, Paulo Afonso Nunes Nassif, Marcos Fabiano Sigwalt, Ronaldo Mafia Cuenca, Orlando Jorge Martins Torres","doi":"10.1590/0102-67202025000015e1884","DOIUrl":"10.1590/0102-67202025000015e1884","url":null,"abstract":"<p><strong>Background: </strong>Affective temperaments are part of the spectrum of mood disorders and comprise the concepts of hyperthymia, dysthymia and cyclothymia. Numerous studies have demonstrated a strong relationship between obesity and mood disorders.</p><p><strong>Aims: </strong>The objective of the present study was to evaluate the frequency of affective temperaments in morbidly obese individuals and controls and to establish a possible association between affective temperaments and morbid obesity.</p><p><strong>Methods: </strong>The study evaluated 106 cases (morbidly obese) and one hundred controls (non-obese). To assess affective temperaments, the Temperament Evaluation in Memphis Pisa and San Diego - Rio de Janeiro TEMPS-Rio de Janeiro scale was applied. Depressive symptoms were assessed using the Hamilton Depression Rating Scale, anxiety symptoms using the Hamilton Anxiety Rating Scale and manic symptoms using the Young Mania Rating Scale. For univariate and multivariate analysis, logistic regression models were adjusted.</p><p><strong>Results: </strong>The presence of at least one affective temperament was 74.5% in the morbidly obese group and 63% in the non-obese group. When comparing the two groups, the statistical analysis of the age subgroup of individuals aged 50 years or over showed an odds ratio of 2.56 (1.07-6.09) for hyperthymic temperament.</p><p><strong>Conclusions: </strong>In the age group of 50 years or more, cases of morbid obesity are significantly more likely (2.56 times) to occur in individuals with a hyperthymic temperament. Among the three types of affective temperaments evaluated, only hyperthymia could be a risk factor for morbid obesity.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1884"},"PeriodicalIF":0.0,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12108123/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144176063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IMPACT OF SLEEVE GASTRECTOMY ON THE NEUTROPHIL-TO-LYMPHOCYTE RATIO AND THE PLATELET-TO-LYMPHOCYTE RATIO AND ITS RELATIONSHIP WITH POSTOPERATIVE WEIGHT LOSS. 袖式胃切除术对中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值的影响及其与术后体重减轻的关系。
Pub Date : 2025-05-23 eCollection Date: 2025-01-01 DOI: 10.1590/0102-67202025000013e1882
Tiago Cavalcanti Iwanaga, Fernando Santa-Cruz, Álvaro Antonio Bandeira Ferraz, Flávio Kreimer

Background: Obesity represents a chronic pro-inflammatory status that contributes to accelerated atherosclerosis and cell aging. Besides the widely used C-reactive protein and ferritin, other inflammatory markers have gained attention, such as neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), which are related with the degree of inflammation in various pathological conditions, including obesity and its comorbidities.

Aims: To compare and monitor the levels of NLR and PLR before and after sleeve gastrectomy (SG).

Methods: Retrospective study that included a total of 622 patients with obesity who underwent SG as primer bariatric surgery in our center. Data regarding the presence of comorbidities, including type 2 diabetes (T2D), high blood pressure (HBP) and non-alcoholic fatty liver disease (NAFLD), variations in body weight and body mass index (BMI), and biochemical markers of inflammation, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and C-reactive protein (CRP) were gathered. Values of NLR and PLR were correlated with weight loss and prognosis of comorbidities within the postoperative period.

Results: The sample was predominantly female (79.3%) with average age 36.91±10.04 years, with comorbidities including HBP (25.1%), T2D (8.0%), and NAFLD (80.1%). Patients with HBP showed reduced NLR and CRP post-intervention, while those with T2D experienced decreased CRP but increased PLR. Correlation analysis found no significant correlation between BMI/weight changes and NLR but significant correlation with PLR. Post-surgery, NLR decreased for previously NAFLD patients, and PLR increased.

Conclusions: According to the results, patients with obesity present a significant decrease in NLR and an increase in PLR after SG.

背景:肥胖是一种慢性促炎状态,有助于加速动脉粥样硬化和细胞衰老。除了广泛使用的c反应蛋白和铁蛋白外,其他炎症标志物也受到了人们的关注,如中性粒细胞与淋巴细胞比率(NLR)和血小板与淋巴细胞比率(PLR),它们与各种病理状态下的炎症程度有关,包括肥胖及其合共病。目的:比较和监测袖式胃切除术(SG)前后NLR和PLR水平。方法:回顾性研究,共纳入622例肥胖患者,这些患者在我们中心接受了SG作为初始减肥手术。收集有关合并症存在的数据,包括2型糖尿病(T2D)、高血压(HBP)和非酒精性脂肪性肝病(NAFLD)、体重和体重指数(BMI)的变化,以及炎症的生化标志物,包括中性粒细胞与淋巴细胞比率(NLR)、血小板与淋巴细胞比率(PLR)和c反应蛋白(CRP)。NLR和PLR值与术后体重减轻和合并症预后相关。结果:患者以女性为主(79.3%),平均年龄36.91±10.04岁,合并症包括HBP(25.1%)、T2D(8.0%)和NAFLD(80.1%)。干预后,HBP患者NLR和CRP降低,而T2D患者CRP降低,PLR升高。相关分析发现BMI/体重变化与NLR无显著相关,但与PLR有显著相关。术后,既往NAFLD患者NLR下降,PLR增加。结论:肥胖患者SG后NLR明显降低,PLR明显升高。
{"title":"IMPACT OF SLEEVE GASTRECTOMY ON THE NEUTROPHIL-TO-LYMPHOCYTE RATIO AND THE PLATELET-TO-LYMPHOCYTE RATIO AND ITS RELATIONSHIP WITH POSTOPERATIVE WEIGHT LOSS.","authors":"Tiago Cavalcanti Iwanaga, Fernando Santa-Cruz, Álvaro Antonio Bandeira Ferraz, Flávio Kreimer","doi":"10.1590/0102-67202025000013e1882","DOIUrl":"10.1590/0102-67202025000013e1882","url":null,"abstract":"<p><strong>Background: </strong>Obesity represents a chronic pro-inflammatory status that contributes to accelerated atherosclerosis and cell aging. Besides the widely used C-reactive protein and ferritin, other inflammatory markers have gained attention, such as neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), which are related with the degree of inflammation in various pathological conditions, including obesity and its comorbidities.</p><p><strong>Aims: </strong>To compare and monitor the levels of NLR and PLR before and after sleeve gastrectomy (SG).</p><p><strong>Methods: </strong>Retrospective study that included a total of 622 patients with obesity who underwent SG as primer bariatric surgery in our center. Data regarding the presence of comorbidities, including type 2 diabetes (T2D), high blood pressure (HBP) and non-alcoholic fatty liver disease (NAFLD), variations in body weight and body mass index (BMI), and biochemical markers of inflammation, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and C-reactive protein (CRP) were gathered. Values of NLR and PLR were correlated with weight loss and prognosis of comorbidities within the postoperative period.</p><p><strong>Results: </strong>The sample was predominantly female (79.3%) with average age 36.91±10.04 years, with comorbidities including HBP (25.1%), T2D (8.0%), and NAFLD (80.1%). Patients with HBP showed reduced NLR and CRP post-intervention, while those with T2D experienced decreased CRP but increased PLR. Correlation analysis found no significant correlation between BMI/weight changes and NLR but significant correlation with PLR. Post-surgery, NLR decreased for previously NAFLD patients, and PLR increased.</p><p><strong>Conclusions: </strong>According to the results, patients with obesity present a significant decrease in NLR and an increase in PLR after SG.</p>","PeriodicalId":72298,"journal":{"name":"Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery","volume":"38 ","pages":"e1882"},"PeriodicalIF":0.0,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12108122/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144176064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Arquivos brasileiros de cirurgia digestiva : ABCD = Brazilian archives of digestive surgery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1